Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $533.87 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $127.88 | 2 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $123.56 | 3 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $108.15 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $18.82 | 1 | $0 (2018) |
| Allergan Inc. | $15.32 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $15.14 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $12.49 | 1 | E.R. Squibb & Sons, L.L.C. ($12.49) |
| 2021 | $100.00 | 1 | E.R. Squibb & Sons, L.L.C. ($100.00) |
| 2019 | $11.07 | 1 | E.R. Squibb & Sons, L.L.C. ($11.07) |
| 2018 | $159.14 | 3 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2017 | $251.17 | 4 | Novartis Pharmaceuticals Corporation ($127.88) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.49 | General |
| Category: Oncology | ||||||
| 06/16/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: Oncology | ||||||
| 08/07/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $11.07 | General |
| Category: Oncology | ||||||
| 04/18/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: DIABETES | ||||||
| 03/27/2018 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 03/06/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2017 | Janssen Scientific Affairs, LLC | DARZALEX (Biological), YONDELIS, ZYTIGA | Food and Beverage | In-kind items and services | $108.15 | General |
| Category: Oncology | ||||||
| 04/03/2017 | Novartis Pharmaceuticals Corporation | BYL719 (Drug) | Food and Beverage | In-kind items and services | $5.63 | General |
| 03/09/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $122.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/06/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 158 | 528 | $79,735 | $47,454 |
| 2022 | 1 | 188 | 646 | $97,417 | $60,287 |
| 2021 | 1 | 199 | 723 | $109,028 | $71,099 |
| 2020 | 1 | 223 | 762 | $114,910 | $56,860 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 528 | $79,735 | $47,454 | 59.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 646 | $97,417 | $60,287 | 61.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 199 | 723 | $109,028 | $71,099 | 65.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 223 | 762 | $114,910 | $56,860 | 49.5% |
About Dr. Michael Savona, M.D
Dr. Michael Savona, M.D is a Internal Medicine healthcare provider based in Wailuku, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750430799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Savona, M.D has received a total of $533.87 in payments from pharmaceutical and medical device companies, with $12.49 received in 2022. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($533.87).
As a Medicare-enrolled provider, Savona has provided services to 768 Medicare beneficiaries, totaling 2,659 services with total Medicare billing of $235,700. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wailuku, HI
- Active Since 01/09/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750430799
Products in Payments
- TAGRISSO (Drug) $125.00
- OPDIVO (Biological) $123.56
- ENTRESTO (Drug) $122.25
- DARZALEX (Biological) $108.15
- TOUJEO (Drug) $18.82
- LINZESS (Drug) $15.32
- Myrbetriq (Drug) $15.14
- BYL719 (Drug) $5.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wailuku
Dr. Sonya Hansen, M.d, M.D
Internal Medicine — Payments: $19,302
Dr. Arleen Ricalde-Garcia, M.d, M.D
Internal Medicine — Payments: $2,239
Daniel Garcia, M.d, M.D
Internal Medicine — Payments: $2,003
Deyaa Mounir, M.d, M.D
Internal Medicine — Payments: $1,939
Melody Jayne, Md, MD
Internal Medicine — Payments: $1,873
Gregory Park, M.d, M.D
Internal Medicine — Payments: $1,262